(Q51575081)

English

Zamifenacin (UK‐76, 654), a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome

scientific article published on June 1, 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

Zamifenacin (UK‐76, 654), a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome (English)

reason for preferred rank

most precise value

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Zamifenacin (UK-76, 654) a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

Lesley A Houghton

1

object named as

L. A. Houghton

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

Peter J Whorwell

3

object named as

P. J. Whorwell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

author name string

J. Rogers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

F. C. Campbell

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

N. S. Williams

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

J. Goka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1997.00189.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218083

14 September 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.1997.00189.x

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.1997.00189.x

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

11

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

561-568

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

Abnormal small-bowel motility demonstrated by radiotelemetry in a patient with irritable colon

1

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

The irritable bowel syndrome: a paroxysmal motor disorder.

2

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

3

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

MOTILITY OF THE PELVIC COLON. IV. ABDOMINAL PAIN ASSOCIATED WITH COLONIC HYPERMOTILITY AFTER MEALS.

5

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics

6

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide

7

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Observations on the mechanism of abdominal pain

8

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

9

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects

11

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients

12

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Altered esophageal pain threshold in irritable bowel syndrome

14

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

18

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Physiological effects of emotion: assessment via hypnosis

19

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Increased colonic motility during exposure to a stressful situation

20

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Bran and irritable bowel syndrome: time for reappraisal

25

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity

26

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study

27

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Irritable colon and depression

28

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Therapeutic usefulness of amitriptyline in spastic colon syndrome

29

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Controlled clinical trial of mepiprazole in irritable bowel syndrome

30

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome

31

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon

32

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Treating irritable bowel syndrome with peppermint oil

37

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

38

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders

39

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

40

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome

42

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Frequency of "functional" gastrointestinal disorders

46

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Organic and functional disorders in 2000 gastroenterology outpatients

47

1 reference

10.1046/J.1365-2036.1997.00189.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00189.X

14 September 2024

Identifiers

10.1046/J.1365-2036.1997.00189.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9218083

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51575081&oldid=2247870510"